August 1, 2024International Journal of Molecular SciencesOpen Access

Metabolic, Mitochondrial, and Inflammatory Effects of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate in Asymptomatic Antiretroviral-Naïve People with HIV

View Full Paper

Ask AI

Bookmark

Restoration of viral-depleted mitochondrial dna occurs during first-line therapy, yet regimens induce notable shifts in circulating lipid and glucose concentrations.
Comparative cohort analysis of 29 treated and 33 antiretroviral-naive individuals reveals elevated alkaline phosphatase alongside decreased cytochrome c oxidase ii synthesis.
Highlights the need to monitor subclinical metabolic changes, as efavirenz therapy enhances cellular recovery despite altering hepatic markers and systemic lipids.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Comparative study reveals subclinical metabolic alterations alongside partial mitochondrial recovery in people with HIV, suggesting therapeutic benefits despite altered lipid markers.

Cite This Study

Barroso et al. (2024) studied this question.

synapsesocial.com/papers/68e5dd9eb6db643587573894 https://doi.org/10.3390/ijms25158418

View Full Paper

Ask AI

Bookmark

Implication

Comparative study reveals subclinical metabolic alterations alongside partial mitochondrial recovery in people with HIV, suggesting therapeutic benefits despite altered lipid markers.

Metabolic, Mitochondrial, and Inflammatory Effects of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate in Asymptomatic Antiretroviral-Naïve People with HIV

Key Points

Discussion

Implication

Cite This Study

Metabolic, Mitochondrial, and Inflammatory Effects of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate in Asymptomatic Antiretroviral-Naïve People with HIV

Key Points

Discussion

Implication

Cite This Study

Keep reading

Keep reading